`Case 1:15-cv-00027-GMS Document 20 Filed 07/31/17 Page 1 of 1 PageID #: 120
`AO 120 (Rev. 08/IQ)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`. Delaware
`filed in the U.S. District Court
`on the following
`Glf Patents.
`D Trademarks or
`( D the patent action involves 35 U.S.C. § 292.):
`
`DOCKET NO.
`
`PLAINTIFF
`
`DATE FILED
`1/8/2015
`
`U.S. DISTRICT COURT
`
`DEFENDANT
`
`Delaware
`
`Salix Pharmaceuticals, Inc. and Dr. Falk Pharma, GmbH
`
`Novel Laboratories, Inc.
`
`PATENTOR
`TRADEMARK NO.
`1 us 8,865,688
`
`DATE OF PA TENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`10/2·1/2014
`
`Dr. Falk Pharma GmbH
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following patent(s)/ trademark(s) have been included:
`
`DATE INCLUDED
`
`·,
`
`PATENTOR
`TRADEMARK NO.
`
`INCLUDED BY
`
`D Amendment
`DATE OF PATENT
`OR TRADEMARK.
`
`D Answer
`
`D Cross Bill
`
`D Other Pleading
`
`HOLDER OF PATENT OR TRADEMARK
`
`1
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`
`DECISION/JUDGEMENT
`
`\:),~'i~~- ~ ,t-i--c-~
`
`CLERK united states 'oistrict Court
`844 N. King Street. Unit 18
`
`Copy 1-Upon initiation of action, mail this copy to Director Copy 3-Upon termination of action, mail this copy to Director
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`